Clinical Trial Update: IC14 for ALS Patients Expanded Access

View source ↗

Summary

The Expanded Access program for IC14 in Amyotrophic Lateral Sclerosis has ended and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• IC14

Snippet

Sponsor: Implicit Bioscience | Conditions: Amyotrophic Lateral Sclerosis | Status: NO_LONGER_AVAILABLE